Monthly Archives: September 2019

Recently, the FDA Allergenic Products Committee voted to approve Aimmune’s drug for reducing the severity of peanut allergies in children and teens. The drug’s brand name is set to be Palforzia and could receive full FDA approval early next year. … Continue reading …